Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults' ischemic stroke.
Renna R, Spagnoletti G, Rippa M, Alfieri G, Barbato S, Candelaresi P, Capezzuto C, Della Rocca G, De Mase A, Di Battista ME, Di Giovanni M, Di Iorio W, Longo K, Loreto V, Maurea C, Napolitano M, Petrillo E, Ranieri A, Salvatore S, Servillo G, Spina E, Villani R, Muto M, Andreone V. Renna R, et al. Among authors: di battista me. Neurol Sci. 2024 Nov 18. doi: 10.1007/s10072-024-07859-0. Online ahead of print. Neurol Sci. 2024. PMID: 39551848
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report.
Maniscalco GT, Manzo V, Di Battista ME, Salvatore S, Moreggia O, Scavone C, Capuano A. Maniscalco GT, et al. Among authors: di battista me. Front Neurol. 2021 Aug 10;12:721502. doi: 10.3389/fneur.2021.721502. eCollection 2021. Front Neurol. 2021. PMID: 34447349 Free PMC article.
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies.
Maniscalco GT, Liotti A, Ferrara AL, Prestipino E, Salvatore S, Di Battista ME, Moreggia O, Di Giulio Cesare D, Vastano R, Belardo M, Napolitano M, Ranieri A, Longo K, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: di battista me. Mult Scler Relat Disord. 2022 Dec;68:104371. doi: 10.1016/j.msard.2022.104371. Epub 2022 Oct 23. Mult Scler Relat Disord. 2022. PMID: 36544318 Free PMC article.
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis.
Maniscalco GT, Di Giulio Cesare D, Liguori V, Manzo V, Prestipino E, Salvatore S, Di Battista ME, Moreggia O, Ziello AR, Andreone V, Scavone C, Capuano A. Maniscalco GT, et al. Among authors: di battista me. J Clin Med. 2023 Jun 23;12(13):4236. doi: 10.3390/jcm12134236. J Clin Med. 2023. PMID: 37445269 Free PMC article.
Epstein-Barr virus infection in patients with MOGAD.
Maniscalco GT, Dinoto A, Foglia MC, Di Battista ME, Moreggia O, Di Giulio Cesare D, Williams M, Rossi FW, Carta S, Chiodega V, Ferrari S, Viola A, de Paulis A, Andreone V, Mariotto S. Maniscalco GT, et al. Among authors: di battista me. Mult Scler. 2024 Dec 13:13524585241298065. doi: 10.1177/13524585241298065. Online ahead of print. Mult Scler. 2024. PMID: 39668776
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: di battista me. Mult Scler Relat Disord. 2024 Jul;87:105594. doi: 10.1016/j.msard.2024.105594. Epub 2024 Apr 6. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects.
Maniscalco GT, Ferrara AL, Liotti A, Manzo V, Di Battista ME, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Alfieri G, Di Iorio W, Della Rocca G, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: di battista me. Mult Scler Relat Disord. 2022 Jun;62:103800. doi: 10.1016/j.msard.2022.103800. Epub 2022 Apr 12. Mult Scler Relat Disord. 2022. PMID: 35462168 Free PMC article.
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.
Costa B, Manzoni C, Bernal-Quiros M, Kia DA, Aguilar M, Alvarez I, Alvarez V, Andreassen O, Anfossi M, Bagnoli S, Benussi L, Bernardi L, Binetti G, Blackburn D, Boada M, Borroni B, Bowns L, Bråthen G, Bruni AC, Chiang HH, Clarimon J, Colville S, Conidi ME, Cope TE, Cruchaga C, Cupidi C, Di Battista ME, Diehl-Schmid J, Diez-Fairen M, Dols-Icardo O, Durante E, Flisar D, Frangipane F, Galimberti D, Gallo M, Gallucci M, Ghidoni R, Graff C, Grafman JH, Grossman M, Hardy J, Hernández I, Holloway GJT, Huey ED, Illán-Gala I, Karydas A, Khoshnood B, Kramberger MG, Kristiansen M, Lewis PA, Lleó A, Madhan GK, Maletta R, Maver A, Menendez-Gonzalez M, Milan G, Miller B, Mol MO, Momeni P, Moreno-Grau S, Morris CM, Nacmias B, Nilsson C, Novelli V, Öijerstedt L, Padovani A, Pal S, Panchbhaya Y, Pastor P, Peterlin B, Piaceri I, Pickering-Brown S, Pijnenburg YAL, Puca AA, Rainero I, Rendina A, Richardson AMT, Rogaeva E, Rogelj B, Rollinson S, Rossi G, Rossmeier C, Rowe JB, Rubino E, Ruiz A, Sanchez-Valle R, Sando SB, Santillo AF, Saxon J, Scarpini E, Serpente M, Smirne N, Sorbi S, Suh E, Tagliavini F, Thompson JC, Trojanowski JQ, Van Deerlin VM, Van der Zee J, Van Broeckhoven C, van Rooij J,… See abstract for full author list ➔ Costa B, et al. Among authors: di battista me. Neurology. 2020 Dec 15;95(24):e3288-e3302. doi: 10.1212/WNL.0000000000010914. Epub 2020 Sep 17. Neurology. 2020. PMID: 32943482 Free PMC article.
28 results